Efficacy of sorafenib plus transcatheter arterial chemoembolization in treating hepatocellular carcinoma with portal vein tumor thrombosis: A meta-analysis
This meta-analysis aimed to evaluate the efficacy of sorafenib plus transcatheter arterial chemoembolization (TACE) in treating hepato-cellular carcinoma (HCC) with portal vein tumor thrombosis (PVTT). Twelve randomized controlled trials published until 28th Sep 2022 were finally included. Of the to...
Saved in:
| Main Authors: | Xu Li, Chen Shanshan, Cao Haijun, Feng Zemin, Yang Chao |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Sciendo
2024-09-01
|
| Series: | Acta Pharmaceutica |
| Subjects: | |
| Online Access: | https://doi.org/10.2478/acph-2024-0019 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy and safety analysis of DEB-TACE for hepatocellular carcinoma with portal vein tumor thrombosis
by: Yan Zhang, et al.
Published: (2025-06-01) -
Management strategies for advanced hepatocellular carcinoma with portal vein tumor thrombosis
by: Jeayeon Park, et al.
Published: (2025-01-01) -
Liver transplantation for advanced hepatocellular carcinoma: Controversy over portal vein tumor thrombosis
by: Kun-Ming Chan, et al.
Published: (2025-04-01) -
Combination of Hepatic Arterial Infusion Chemotherapy with Tyrosine Kinase Inhibitor Provides Better Survival in Advanced Hepatocellular Carcinoma Patients
by: Liu CW, et al.
Published: (2025-05-01) -
Portal vein thrombosis in patients with liver cirrhosis
by: Savić Željka, et al.
Published: (2024-01-01)